Hans Moebius serves as Executive at Athira Pharma, Inc., where they oversee executive responsibilities. Since joining the company, Hans Moebius has executed 12 insider transactions totaling $45.3K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jan 4, 2024 involved receiving (via award) 10,000 shares valued at $0.
Hans Moebius currently holds 91,482 shares of Athira Pharma, Inc. (ATHA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Hans Moebius has been a net buyer of ATHA stock. They have purchased $45.3K and sold $0 worth of shares.
Hans Moebius's most recent insider trade was on Jan 4, 2024, when they sold 10,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $1.35 |
| Discretionary |
| May 18, 2023 | ATHA | $18.7K | Award | 7,764 | $2.41 | Discretionary |
| Nov 15, 2022 | ATHA | $16.4K | Purchase | 5,000 | $3.29 | Discretionary |
| Oct 13, 2022 | ATHA | $10.6K | Option Exercise | 7,881 | $1.35 | Discretionary |
| Jun 28, 2022 | ATHA | $28.8K | Purchase | 10,000 | $2.88 | Discretionary |
| Jun 22, 2022 | ATHA | $0 | Award | 10,000 | $N/A | Discretionary |
| May 18, 2022 | ATHA | $12.0K | Award | 1,699 | $7.06 | Discretionary |
| Nov 18, 2021 | ATHA | $10.4K | Award | 829 | $12.51 | Discretionary |
| Jul 21, 2021 | ATHA | $21.3K | Option Exercise | 15,762 | $1.35 | Discretionary |
| Jul 21, 2021 | ATHA | $17.0K | Option Exercise | 12,610 | $1.35 | Discretionary |
| May 18, 2021 | ATHA | $29.7K | Award | 2,055 | $14.45 | Discretionary |